enVVeno Medical (NVNO) Long-Term Investments (2022 - 2026)

enVVeno Medical's Long-Term Investments history runs 5 years deep, the most recent figure standing at $24.9 million for Q1 2026.

• In Q1 2026, Long-Term Investments fell 35.99% year-over-year to $24.9 million; the TTM figure through Mar 2026 stood at $24.9 million (down 35.99% YoY), while the FY2025 annual figure was $25.1 million, down 39.37% from the prior year.
• Long-Term Investments was $24.9 million for Q1 2026 at enVVeno Medical, down from $25.1 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $48.4 million in Q3 2024 to a low of $2.4 million in Q3 2022.
• Historically, Long-Term Investments has averaged $33.5 million across 5 years, with a median of $36.6 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments jumped 56.4% in 2024, then slumped 39.37% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $34.5 million in 2022, then grew by 24.06% to $42.8 million in 2023, then dropped by 3.27% to $41.4 million in 2024, then slumped by 39.37% to $25.1 million in 2025, then slipped by 0.8% to $24.9 million in 2026.
• The last three Long-Term Investments figures came in at $24.9 million (Q1 2026), $25.1 million (Q4 2025), and $31.0 million (Q3 2025), per Business Quant data.